Bellevue Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-65,900
| Closed | -$1.61M | – | 220 |
|
|
2021
Q2 | $1.61M | Hold |
65,900
| – | – | 0.02% | 144 |
|
|
2021
Q1 | $1.7M | Buy |
65,900
+21,000
| +47% | +$542K | 0.02% | 145 |
|
|
2020
Q4 | $2.4M | Hold |
44,900
| – | – | 0.03% | 143 |
|
|
2020
Q3 | $1.85M | Hold |
44,900
| – | – | 0.03% | 145 |
|
|
2020
Q2 | $2.18M | Buy |
44,900
+2,900
| +7% | +$141K | 0.03% | 133 |
|
|
2020
Q1 | $1.78M | Buy |
42,000
+2,000
| +5% | +$84.5K | 0.03% | 133 |
|
|
2019
Q4 | $1.71M | Sell |
40,000
-50,400
| -56% | -$2.16M | 0.03% | 134 |
|
|
2019
Q3 | $3.25M | Sell |
90,400
-13,400
| -13% | -$482K | 0.06% | 120 |
|
|
2019
Q2 | $2.78M | Hold |
103,800
| – | – | 0.05% | 121 |
|
|
2019
Q1 | $2.79M | Buy |
103,800
+8,000
| +8% | +$215K | 0.15% | 96 |
|
|
2018
Q4 | $1.55M | Buy |
95,800
+38,800
| +68% | +$627K | 0.1% | 100 |
|
|
2018
Q3 | $1.18M | Buy |
+57,000
| New | +$1.18M | 0.08% | 122 |
|
|
2018
Q2 | – | Sell |
-34,550
| Closed | -$776K | – | 139 |
|
|
2018
Q1 | $776K | Sell |
34,550
-500
| -1% | -$11.2K | 0.08% | 113 |
|
|
2017
Q4 | $1.06M | Sell |
35,050
-81,950
| -70% | -$2.47M | 0.11% | 109 |
|
|
2017
Q3 | $4.41M | Sell |
117,000
-69,000
| -37% | -$2.6M | 0.46% | 57 |
|
|
2017
Q2 | $5.85M | Buy |
186,000
+141,000
| +313% | +$4.44M | 0.69% | 54 |
|
|
2017
Q1 | $1.55M | Hold |
45,000
| – | – | 0.21% | 87 |
|
|
2016
Q4 | $1.3M | Hold |
45,000
| – | – | 0.27% | 79 |
|
|
2016
Q3 | $1.43M | Hold |
45,000
| – | – | 0.26% | 86 |
|
|
2016
Q2 | $1.46M | Hold |
45,000
| – | – | 0.27% | 85 |
|
|
2016
Q1 | $1.26M | Buy |
+45,000
| New | +$1.26M | 0.23% | 91 |
|